|
gptkbp:instance_of
|
gptkb:skincare_product
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:scopolamine
|
|
gptkbp:activities
|
blocks acetylcholine receptors
|
|
gptkbp:application
|
behind the ear
|
|
gptkbp:approves
|
gptkb:1979
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Transderm_Scop
|
|
gptkbp:class
|
anticholinergic
anticholinergic agent
|
|
gptkbp:clinical_trial
|
Phase III
prevent nausea and vomiting
|
|
gptkbp:contraindication
|
gptkb:sneaker
gptkb:Insurance_Company
urinary retention
pregnancy category C
|
|
gptkbp:dosage_form
|
gptkb:spacecraft
|
|
gptkbp:duration
|
up to 72 hours
|
|
gptkbp:effective_date
|
FDA approved
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:form
|
single-use patch
|
|
gptkbp:formulation
|
scopolamine 1.5 mg
|
|
gptkbp:frequency
|
every 72 hours
|
|
gptkbp:has_ability
|
1.5 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Transderm Scop
|
|
gptkbp:indication
|
chemotherapy-induced nausea and vomiting
postoperative nausea and vomiting
radiation therapy-induced nausea and vomiting
|
|
gptkbp:ingredients
|
gptkb:scopolamine
|
|
gptkbp:interacts_with
|
gptkb:beer
antihistamines
CNS depressants
|
|
gptkbp:is_available_on
|
prescription medication
|
|
gptkbp:is_used_for
|
motion sickness
|
|
gptkbp:lifespan
|
about 8 hours
|
|
gptkbp:manager
|
transdermal
|
|
gptkbp:manufacturer
|
gptkb:Novartis
|
|
gptkbp:marketed_as
|
Transderm Scop brand name
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:packaging
|
single-use pouch
|
|
gptkbp:pharmacokinetics
|
transdermal absorption
|
|
gptkbp:population
|
adults
children over 2 years old
|
|
gptkbp:requires
|
prescription only
|
|
gptkbp:side_effect
|
confusion
drowsiness
constipation
dry mouth
blurred vision
tachycardia
urinary retention
|
|
gptkbp:storage
|
room temperature
|